Effect of chronic chlorpromazine administration or prior treatment with reserpine on brain apomorphine concentrations and apomorphine-induced sterotyped behaviour in the rat.
D000818:Animals; D001058:Apomorphine / Q000032:analysis* / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects*; D002746:Chlorpromazine / Q000008:administration & dosage / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D012110:Reserpine / Q000008:administration & dosage / Q000494:pharmacology*; D013239:Stereotyped Behavior / Q000187:drug effects*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D013997:Time Factors
D012110:Reserpine; D001058:Apomorphine; D002746:Chlorpromazine